Table 2 Demographic and baseline characteristics of all patients on admission to our ICU.
All patients | Range | |
|---|---|---|
n | 184 | |
Male | 134 (72.8%) | |
Age [years] | 67 (61; 73) | 25–92 |
Body-Mass-Index [kg/m2] | 29.22 (26.04; 33.60) | 18.94–70.31 |
Time from first symptom to hospital admission [days] | 5 (0; 7) | 0–23 |
Time from first symptom to admission to our ICU [days] | 11 (5; 15) | 0–35 |
Time from first symptom to ECMO therapy [days] | 15 (11; 23) | 0–31 |
Direct transfer to our ICU from other hospital | 121 (65.8%) | |
External tracheostomy | 14 (7.6%) | |
External intubation | 133 (72.3%) | |
Invasive mechanical ventilation before admission to our ICU [days| | 2 (0; 7) | 0–20 |
NIV before admission to our ICU [days| | 2 (1; 4) | 1–22 |
Charlson ComorbidityIndex | 3 (2; 5) | 0–12 |
Arterial Hypertension | 131 (71.2%) | |
Cardiovascular disease | 45 (24.5%) | |
Neurovascular symptoms | 18 (9.8%) | |
Coronary artery disease | 31 (16.8%) | |
Thrombembolic events in medical history | 11 (6.0%) | |
Chronic arrhythmias | 37 (20.1%) | |
COPD | 13 (7.1%) | |
Other pulmonary disease | 11 (6.0%) | |
Nicotine abuse | 12 (6.5%) | |
Diabetes mellitus | 79 (42.9%) | |
Previous organ or bone marrow transplantation | 9 (4.9%) | |
Chronic renal failure | 28 (15.2%) | |
Chronic need of renal replacement therapy | 8 (4.3%) | |
Admission with trauma | 8 (4.3%) | |
ACE inhibitors | 14 (7.6%) | |
AT2 receptor blocker | 85 (46.2%) | |
Beta blocker | 82 (44.6%) | |
Antithrombotic drug | 49 (26.8%) | |
DOAC | 30 (16.4%) | |
Corticosteroids | 21 (11.5%) | |
Immunosuppressive drugs | 10 (5.5%) | |
Nosocomial infection | 19 (10.3%) |
